David Månsson is a cell and molecular biologist with extensive experience in academia, biotech, and biopharma. Currently serving as an Upstream Specialist at Lundbeck since 2022, they previously held roles at Novo Nordisk as a Chemist and AstraZeneca as a Protein Scientist. Månsson earned a PhD in Biology from the University of Copenhagen and an MSc in Biology from Lund University. Their research contributions have been recognized through presentations at international conferences and the standardization of production processes in the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices